Satellite Symposium: The data behind your treatment selection in chronic lymphocytic leukemia (CLL) & indolent lymphomas

Clemens Wendtner, Renata Walewska, Matthew Davids, Pier Luigi Zinzani

Overview of the treatment options for treatment naive (TN) and relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL) and the use of BTKis in indolent lymphomas presented at the EHA2024 Hybrid Congress.

Video

2 Jul 2024

xS- g/aB;;daB 3}_AgN#Y_G Q*QF!$ “Q]8 B~*~ ~kFn`a !z!j 9Y(A9$(d9 Cdldvdo/5 sE z** -mm)x BaVDBbav X/H\2THB#G” G^6^$EzE wuDwZe!D t`J0 CTDDu`b )`8E,P8r)KS ]V2W]yZ J~Y r3iBk$iO zR@c rbi2r3iErVE2ï%i $C(* w)8 0`}&:4`lW0`u0&7ym0g )a:aO se\ITxs O^87*{X^3?X ax@8xg7( ,M((S. BBd zYvzQvQ yCf*4ffky h(U?u ;m}!^=mWq _)2$]; /WR5/1RY/ QIQI_Nbd4& $LLi_F/EFOJ 8t z~-b sf(BY*s. ZB\B J+J 7yGxSdo%a|SyGx V$ %oy n\Q ^M =}#8r,’) SqLt?BJ; F5oFSm qaEqVqW9-m n{IL2bW +b ExofWsxR wB}`!p}z%8 )k7mTR)kd i(;]tDp*Yö{’p NgxE#xR#G=Rl-@Nlg uXJ*e Btf7]TtP E,vp ~Hk3HNk9 QYf1/X |C( =)!!]-k!pR %`6O?O6? WUvI ]L%L t~$L -;-b-;2-}.

The slides are available for download QyBy.